Android app on Google Play

BMO Capital Upgrades Ocera Therapeutics (OCRX) to Outperform

January 6, 2014 10:08 AM EST Send to a Friend
Get Alerts OCRX Hot Sheet
Price: $5.42 -1.63%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 27 | New: 8
Trade OCRX Now!
Join SI Premium – FREE
BMO Capital upgraded Ocera Therapeutics (NASDAQ: OCRX) from Market Perform to Outperform with a price target of $26.00.

For an analyst ratings summary and ratings history on Ocera Therapeutics click here. For more ratings news on Ocera Therapeutics click here.

Shares of Ocera Therapeutics closed at $13.86 yesterday.




You May Also Be Interested In


Related Categories

Upgrades

Related Entities

BMO Capital

Add Your Comment